Literature DB >> 8836119

Presence of pro-forms of decorin and biglycan in human articular cartilage.

P J Roughley1, R J White, J S Mort.   

Abstract

The proteoglycans decorin and biglycan in extracts of human articular cartilage were analysed by SDS/PAGE and immunoblotting, using antisera raised to peptide sequences present in the pro-regions and the mature core proteins. In adult cartilage, both pro-forms and mature processed forms of the proteoglycan core protein were observed for both decorin and biglycan. In the case of biglycan, it was also shown that additional proteolytic processing takes place after removal of the propeptide and that this accounts for the presence of non-glycanated forms of the molecule. For both decorin and biglycan, the relative abundance of the pro-forms was much less in the juvenile than the adult. Different adult connective tissues, including meniscus, tendon and intervertebral disc were also examined for the presence of pro-forms of the proteoglycans. While the mature form of decorin was present at a similar level in extracts of all tissues examined, the pro-form was only detected in the articular cartilage. In the case of biglycan, the abundance of the mature form was more varied, with high levels in articular cartilage, intermediate levels in meniscus and the annulus fibrosus of the intervertebral disc, low levels in the nucleus pulposus of the intervertebral disc, and non-detectable levels in the patellar tendon. The pro-form of biglycan was detected in the disc tissue extracts, albeit at a lower level than in articular cartilage, but was not detected in the meniscus or tendon. The proportion of the pro-form relative to the mature form of biglycan was, however, higher in the nucleus pulposus of the intervertebral disc than in articular cartilage. Thus, the persistence of pro-forms of both decorin and biglycan is a feature of the extracellular matrix of some connective tissues, although their abundance is both tissue- and age-dependent, with adult articular cartilage being a particularly rich source.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836119      PMCID: PMC1217686          DOI: 10.1042/bj3180779

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA.

Authors:  T Krusius; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent.

Authors:  M S Bernatowicz; G R Matsueda
Journal:  Anal Biochem       Date:  1986-05-15       Impact factor: 3.365

4.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

5.  Signal sequences. The limits of variation.

Authors:  G von Heijne
Journal:  J Mol Biol       Date:  1985-07-05       Impact factor: 5.469

6.  Age-related changes in the structure of the proteoglycan subunits from human articular cartilage.

Authors:  P J Roughley; R J White
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

7.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

8.  The murine decorin. Complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation.

Authors:  T Scholzen; M Solursh; S Suzuki; R Reiter; J L Morgan; A M Buchberg; L D Siracusa; R V Iozzo
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

9.  Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone.

Authors:  L W Fisher; G R Hawkins; N Tuross; J D Termine
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

10.  Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages.

Authors:  L C Rosenberg; H U Choi; L H Tang; T L Johnson; S Pal; C Webber; A Reiner; A R Poole
Journal:  J Biol Chem       Date:  1985-05-25       Impact factor: 5.157

View more
  16 in total

Review 1.  The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways.

Authors:  J S Mort; D J Buttle
Journal:  Mol Pathol       Date:  1999-02

Review 2.  The bone morphogenetic protein 1/Tolloid-like metalloproteinases.

Authors:  Delana R Hopkins; Sunduz Keles; Daniel S Greenspan
Journal:  Matrix Biol       Date:  2007-05-18       Impact factor: 11.583

3.  Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1).

Authors:  Zofia von Marschall; Larry W Fisher
Journal:  Biochem Biophys Res Commun       Date:  2009-12-22       Impact factor: 3.575

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

5.  Differential effects of interleukin-1 and transforming growth factor beta on the synthesis of small proteoglycans by rabbit articular chondrocytes cultured in alginate beads as compared to monolayers.

Authors:  M Demoor-Fossard; M Boittin; F Redini; J P Pujol
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

6.  Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.

Authors:  R Sztrolovics; R J White; A R Poole; J S Mort; P J Roughley
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

7.  Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosis-resistant human arteries by mass spectrometry.

Authors:  Paul Talusan; Shahinaz Bedri; Suping Yang; Taj Kattapuram; Nilsa Silva; Peter J Roughley; James R Stone
Journal:  Mol Cell Proteomics       Date:  2005-06-21       Impact factor: 5.911

8.  Aggrecan degradation in human intervertebral disc and articular cartilage.

Authors:  R Sztrolovics; M Alini; P J Roughley; J S Mort
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

9.  Proteoglycans and catabolic products of proteoglycans present in ligament.

Authors:  Mirna Z Ilic; Phillip Carter; Alicia Tyndall; Jayesh Dudhia; Christopher J Handley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

10.  HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties.

Authors:  Christian V Recktenwald; Sandra Leisz; André Steven; Kousaku Mimura; Anja Müller; Jens Wulfänger; Rolf Kiessling; Barbara Seliger
Journal:  J Biol Chem       Date:  2012-05-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.